HintMD is adding medical-grade skincare to the platform that popularized Botox subscriptions earlier this year. HintMD’s patent-pending software allows physicians, such as plastic surgeons and dermatologists, to turn any treatment plan into a monthly subscription payment for their patients. By introducing skincare subscriptions, physicians can now offer professional-grade products delivered directly to the patient’s door, at no cost. Patients can control the delivery frequency using the app, to truly personalize their aesthetic journey.
“I have over 400 patients using HintMD aesthetic subscriptions, and it has transformed my practice and the patient experience,” says Dr. A. Jay Burns, MD, FACS. “The easy subscription payment allows more of my patients to stay on track with their treatment plan and go for the full correction they are seeking.”
HintMD is launching skincare subscriptions with physician dispensed Alastin Skincare. HintMD practices will be able to offer Alastin’s entire line of scientifically proven and clinically-tested skincare formulations, including their newest product, TransFORM Body Treatment with TriHex Technology. Additional medical-grade skincare brands will be available on the HintMD platform in the coming weeks.
“The HintMD platform is perfectly aligned to Alastin’s corporate goals of innovation and value creation for aesthetic physicians and their practices. As the fastest growing skincare company in the US aesthetics market, we look forward to continuing our growth with the HintMD team,” says Jim Hartman, Chief Commercial Officer, Alastin Skincare.
Founded by industry veterans, Aubrey Rankin and Vojin Kos, HintMD is solving a number of problems faced by the aesthetics industry such as commoditization, patient compliance, and perceived barriers to entry by consumers.
“HintMD makes it easier for patients to access the industry’s best physicians, medical-grade products, and commit to their doctor prescribed skincare regimen,” says Aubrey Rankin, CEO and Co-Founder, HintMD. “This creates better outcomes and more consistent results for patients.”Next Story